ROP vs NBIS vs WDAY
161 measures in 16 categories, one definition each, computed from filings and market data.
ROP70.3
Roper Technologies, Inc.
Technology · Software - Application
$382.71 +0.07%$37.9B mkt cap
Score DNA
NBIS43.6
Nebius Group N.V.
Technology · Software - Application
$165.47 −12.18%$39.7B mkt cap
Score DNA
Price, rebased to 100 three years ago
ROP NBIS WDAY · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 2 | 0 |
| Insider $ bought, 180d | — | $0.05M | — |
| Congress purchases, 180d | 1 | 0 | 12 |
| Last Congress purchase | 2026-03-27 | — | 2026-08-18 |
| 13F net change in holders | −67 | +334 | −24 |
| ETFs adding shares, 30d | 1,090 | 489 | 1,340 |
| ETFs trimming, 30d | 1,038 | 286 | 1,238 |
| Net ETF funds, 30d | +52 | +203 | +102 |
Valuation
16 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| P/E (TTM) | 15.1x
12th
|
644.7x
99th
|
36.8x
60th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.54
21st
|
— | — |
| Price / sales | 4.6x
53rd
|
29.3x
96th
|
4.5x
51st
|
| Price / book | 2.0x
18th
|
3.8x
41st
|
7.1x
69th
|
| Price / tangible book | — | 8.0x
52nd
|
64.5x
95th
|
| Price / free cash flow | 14.4x
37th
|
— | 16.2x
44th
|
| Price / operating cash flow | 14.2x
42nd
|
7.6x
9th
|
14.9x
46th
|
| Enterprise value | $48.8B
90th
|
$41.7B
88th
|
$46.4B
89th
|
| EV / sales | 5.9x
71st
|
30.8x
96th
|
4.6x
55th
|
| EV / EBITDA | 10.9x
19th
|
43.7x
75th
|
27.8x
63rd
|
| EV / EBIT | 14.5x
22nd
|
239.0x
95th
|
35.6x
59th
|
| EV / free cash flow | 18.6x
51st
|
— | 16.3x
44th
|
| Earnings yield | 6.6%
93rd
|
0.2%
40th
|
2.7%
64th
|
| FCF yield | 6.9%
69th
|
-14.8%
4th
|
6.2%
62nd
|
| Operating cash flow yield | 7.1%
63rd
|
13.2%
92nd
|
6.7%
60th
|
| Graham number (per share) | $316.38
100th
|
$13.50
39th
|
$53.89
79th
|
Profitability (TTM)
12 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| Gross margin | 69.5%
48th
|
74.3%
57th
|
75.8%
65th
|
| EBITDA margin | 54.3%
93rd
|
70.5%
96th
|
16.4%
56th
|
| Operating margin | 28.0%
86th
|
-49.3%
8th
|
12.0%
62nd
|
| EBIT margin | 40.7%
90th
|
12.9%
63rd
|
12.8%
62nd
|
| Net margin | 30.2%
91st
|
4.5%
49th
|
12.3%
64th
|
| NOPAT margin | 23.5%
88th
|
-42.3%
10th
|
11.7%
64th
|
| FCF margin | 31.7%
83rd
|
-434.2%
2nd
|
28.0%
74th
|
| Operating cash flow margin | 32.2%
80th
|
— | 30.3%
75th
|
| R&D / revenue | 0.0%
0th
|
26.3%
80th
|
27.7%
83rd
|
| SG&A / revenue | 41.6%
57th
|
35.2%
40th
|
36.1%
43rd
|
| Stock comp / revenue | 2.3%
15th
|
13.3%
75th
|
16.2%
83rd
|
| Effective tax rate | 15.8%
22nd
|
14.2%
18th
|
2.6%
9th
|
Returns on capital
11 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| ROE (on average equity) | 13.1%
65th
|
0.9%
41st
|
16.0%
72nd
|
| ROA | 7.3%
68th
|
0.4%
40th
|
7.4%
69th
|
| ROIC | 6.6%
50th
|
-4.6%
33rd
|
17.4%
70th
|
| ROCE | 10.6%
64th
|
0.7%
35th
|
14.0%
71st
|
| Return on tangible assets | 9.9%
74th
|
1.1%
39th
|
7.7%
62nd
|
| Cash ROIC (OCF / invested capital) | 9.0%
19th
|
42.6%
59th
|
45.1%
61st
|
| Gross profitability (GP / assets) | 16.4%
20th
|
2.8%
7th
|
48.6%
67th
|
| ROIC, 3-yr average | 5.3%
52nd
|
— | 14.8%
73rd
|
| ROIC, 5-yr average | 5.5%
59th
|
— | 7.5%
65th
|
| ROE, 5-yr average | 8.9%
70th
|
— | 7.7%
65th
|
| Incremental ROIC | 42.8%
62nd
|
-5.6%
37th
|
-22.8%
28th
|
Growth
17 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| Revenue growth (TTM YoY) | 10.9%
34th
|
583.4%
99th
|
13.4%
43rd
|
| Revenue growth (QoQ) | 0.6%
16th
|
45.9%
96th
|
4.3%
43rd
|
| Revenue CAGR, 3 yr | 12.7%
45th
|
— | 14.9%
56th
|
| Revenue CAGR, 5 yr | 10.2%
21st
|
— | 16.8%
51st
|
| Gross profit CAGR, 3 yr | 12.6%
37th
|
— | 15.9%
56th
|
| Operating income CAGR, 3 yr | 12.1%
24th
|
— | — |
| Net income growth (TTM YoY) | 62.7%
67th
|
-81.8%
0th
|
114.6%
73rd
|
| Net income CAGR, 3 yr | 26.1%
74th
|
— | — |
| EPS growth (TTM YoY) | 71.9%
67th
|
-84.4%
0th
|
131.7%
74th
|
| EPS CAGR, 3 yr | 28.0%
71st
|
— | — |
| EPS CAGR, 5 yr | 19.5%
66th
|
— | — |
| FCF growth (TTM YoY) | 13.0%
25th
|
— | 18.9%
35th
|
| FCF CAGR, 3 yr | 36.9%
58th
|
— | 22.7%
37th
|
| Operating cash flow CAGR, 3 yr | 34.1%
62nd
|
— | 19.5%
34th
|
| Book value CAGR, 3 yr | 5.3%
52nd
|
— | 2.9%
44th
|
| Dividend CAGR, 3 yr | 4.5%
50th
|
— | — |
| Sustainable growth rate | 11.1%
36th
|
0.9%
3rd
|
16.0%
53rd
|
Margin history & stability
7 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| Gross margin, 3-yr average | 69.4%
46th
|
— | 75.7%
64th
|
| Operating margin, 3-yr average | 28.2%
91st
|
— | 7.4%
58th
|
| Net margin, 3-yr average | 24.3%
92nd
|
— | 12.8%
67th
|
| FCF margin, 3-yr average | 31.4%
85th
|
— | 27.3%
75th
|
| Revenue stability (0-1) | 0.96
44th
|
— | 1.00
96th
|
| Earnings stability (0-1) | 0.76
69th
|
— | 0.55
48th
|
| Margin stability (0-1) | 0.99
95th
|
— | 0.98
74th
|
Liquidity (latest quarter)
7 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| Cash & short-term investments | $364.9M
45th
|
$8.0B
99th
|
$3.4B
90th
|
| Net cash (− = net debt) | −$11.0B
1st
|
−$2.0B
10th
|
−$369.0M
26th
|
| Working capital | −$1.6B
4th
|
$7.2B
100th
|
−$604.0M
8th
|
| Current ratio | 0.55
2nd
|
4.03
78th
|
0.91
19th
|
| Quick ratio | 0.51
2nd
|
4.03
78th
|
0.91
20th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.11
4th
|
3.37
83rd
|
0.52
32nd
|
| Defensive interval (days) | 161 days
11th
|
2,079 days
93rd
|
300 days
40th
|
Leverage & solvency (latest quarter)
13 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| Total debt | $11.3B
99th
|
$10.1B
98th
|
$3.8B
88th
|
| Debt / equity | 0.61
70th
|
0.97
77th
|
0.58
67th
|
| Net debt / equity | 0.59
88th
|
0.19
75th
|
0.06
61st
|
| Debt / assets | 32.2%
76th
|
36.0%
80th
|
23.8%
63rd
|
| Debt / capital | 37.7%
70th
|
49.3%
77th
|
36.9%
67th
|
| Debt / EBITDA | 2.52
57th
|
10.52
92nd
|
2.26
50th
|
| Net debt / EBITDA | 2.44
82nd
|
2.11
79th
|
0.22
62nd
|
| Interest coverage (EBIT / interest) | 8.6x
60th
|
0.8x
34th
|
11.7x
70th
|
| Cash interest coverage | 6.8x
34th
|
24.8x
67th
|
27.8x
69th
|
| Debt payback (years of OCF) | 4.2 yrs
87th
|
1.9 yrs
60th
|
1.2 yrs
53rd
|
| Liabilities / assets | 46.8%
45th
|
63.0%
68th
|
59.3%
62nd
|
| IS credit model rating | BBB | BB+ | A+ |
| Implied credit spread (bps) | 275
57th
|
400
68th
|
125
33rd
|
Efficiency
11 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| Asset turnover | 0.24
13th
|
0.08
5th
|
0.60
53rd
|
| Fixed asset turnover | 52.18
93rd
|
0.09
1st
|
5.62
24th
|
| Inventory turnover | 18.2
65th
|
— | — |
| Receivables turnover | 8.6
69th
|
7.9
63rd
|
5.8
42nd
|
| Days sales outstanding | 43 days
33rd
|
46 days
39th
|
63 days
60th
|
| Days inventory outstanding | 20 days
46th
|
— | — |
| Days payables outstanding | 24 days
42nd
|
441 days
99th
|
15 days
20th
|
| Cash conversion cycle (days) | 39 days
69th
|
−394 days
1st
|
48 days
78th
|
| Capex / revenue | 0.6%
26th
|
822.2%
98th
|
2.3%
66th
|
| Capex / depreciation | 0.04
5th
|
14.26
97th
|
0.65
69th
|
| Operating expense ratio | 42.0%
18th
|
107.3%
93rd
|
63.4%
52nd
|
Cash flow & earnings quality
7 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| Operating cash flow / net income | 1.07
16th
|
85.36
100th
|
2.46
66th
|
| FCF / net income | 1.05
21st
|
−95.52
0th
|
2.27
68th
|
| FCF / operating cash flow | 98.3%
82nd
|
-111.9%
3rd
|
92.3%
39th
|
| Capex / operating cash flow | 1.7%
18th
|
211.9%
97th
|
7.7%
61st
|
| Accruals ratio | -0.5%
90th
|
-31.4%
7th
|
-10.8%
51st
|
| Sloan accruals ratio | -2.2%
61st
|
27.6%
95th
|
-36.4%
3rd
|
| Earnings quality score (0-1) | 1.00
80th
|
0.75
11th
|
0.75
11th
|
Scores & forensic checks
15 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| IS score | 70
74th
|
44
33rd
|
75
85th
|
| IS profitability | 74
84th
|
21
31st
|
66
77th
|
| IS growth | 65
50th
|
40
14th
|
68
53rd
|
| IS value | 71
93rd
|
35
41st
|
34
35th
|
| IS momentum | 86
67th
|
70
33rd
|
93
82nd
|
| IS risk (safety) | 65
44th
|
80
50th
|
80
50th
|
| IS quality | 82
82nd
|
54
38th
|
81
80th
|
| IS balance sheet | 49
29th
|
64
43rd
|
78
60th
|
| IS earnings quality | 80
93rd
|
39
29th
|
59
62nd
|
| IS cash flow | 74
54th
|
35
15th
|
85
80th
|
| Piotroski F-score (0-9) | 8
85th
|
5
24th
|
7
57th
|
| Altman Z-score | 2.5
44th
|
3.2
54th
|
3.5
55th
|
| Beneish M-score | −2.41
76th
|
0.08
97th
|
−2.72
51st
|
| Ohlson O-score | −8.77
31st
|
−7.85
52nd
|
−8.14
45th
|
| IS credit score | 59
43rd
|
49
28th
|
77
62nd
|
Size (TTM)
8 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| Market cap | $37.9B
88th
|
$39.7B
88th
|
$46.0B
89th
|
| Revenue | $8.3B
93rd
|
$1.4B
63rd
|
$10.2B
94th
|
| EBITDA | $4.5B
96th
|
$955.8M
87th
|
$1.7B
90th
|
| Net income | $2.5B
94th
|
$61.6M
56th
|
$1.3B
90th
|
| Free cash flow | $2.6B
92nd
|
−$5.9B
0th
|
$2.8B
93rd
|
| Total assets | $35.2B
93rd
|
$28.0B
91st
|
$15.9B
90th
|
| Shareholders' equity | $18.7B
94th
|
$10.3B
90th
|
$6.5B
86th
|
| Employees | 19,400
92nd
|
1,543
39th
|
20,896
95th
|
Price performance
9 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| 1 day | +0.1% | −12.2% | −3.0% |
| 1 week | +5.1% | −25.1% | +2.3% |
| 1 month | +2.4% | −24.1% | −4.2% |
| 3 months | +5.5% | −9.4% | +29.6% |
| 6 months | +5.6% | +5.3% | +54.1% |
| Year to date | −11.9% | +84.0% | −7.3% |
| 1 year | −23.4% | +31.5% | −18.7% |
| 3 years, cumulative | −22.9% | — | −14.1% |
| 5 years, cumulative | −13.2% | — | −25.4% |
Technicals
4 measures| Measure | ROP | NBIS | WDAY |
|---|---|---|---|
| RSI 14 | 59.0 | 30.6 | 52.1 |
| From 52-week high | −26.3% | −44.8% | −22.9% |
| From 52-week low | +25.1% | +125.1% | +72.9% |
| Beta | 0.75 | 1.46 | 1.07 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17